Κυριακή 8 Μαΐου 2022

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial

alexandrossfakianakis shared this article with you from Inoreader

1-s2.0-S1473309922X00054-cov150h.gif

Publication date: Available online 6 May 2022

Source: The Lancet Infectious Diseases

Author(s): Moses Laman, Livingstone Tavul, Stephan Karl, Bethuel Kotty, Zebede Kerry, Stephen Kumai, Anna Samuel, Lina Lorry, Lincoln Timinao, S Cade Howard, Leo Makita, Lucy John, Sibauk Bieb, James Wangi, Jeffrey M Albert, Michael Payne, Gary J Weil, Daniel J Tisch, Catherine M Bjerum, Leanne J Robinson

View on the web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου